Pipeline
| Program/Target | Indication | Discovery | Lead Optimization |
IND Enabling |
Phase 1 | Phase 2 | Phase 3 | Country/Region |
|---|
FWD1802SERD |
ER+ Breast Cancer |
|
|
|||||
FWD1802SERD (combo) |
ER+ Breast Cancer |
|
|
|||||
UNDISCLOSED |
KRAS G12C |
|
||||||
UNDISCLOSED |
KRAS G12D |
|
||||||
UNDISCLOSED |
FGFR2 |
|
||||||
UNDISCLOSED |
HPK1 |
|
||||||
FWB1313 |
IL13 |
|
||||||
FWB19144 |
FGFR2b |
|
||||||
FWB2114 |
New Target |
|
||||||